emanuela felley-bosco
emanuela felley-bosco
Laboratory of Molecular Oncology
Verified email at - Homepage
Cited by
Cited by
Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression
S Ambs, WG Merriam, WP Bennett, E Felley-Bosco, MO Ogunfusika, ...
Cancer Research 58 (2), 334-341, 1998
Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53.
K Forrester, S Ambs, SE Lupold, RB Kapust, EA Spillare, WC Weinberg, ...
Proceedings of the National Academy of Sciences 93 (6), 2442-2447, 1996
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
M Carbone, PS Adusumilli, HR Alexander Jr, P Baas, F Bardelli, A Bononi, ...
CA: a cancer journal for clinicians 69 (5), 402-429, 2019
Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer
S Ambs, WP Bennett, WG Merriam, MO Ogunfusika, SM Oser, ...
Journal of the National Cancer Institute 91 (1), 86-88, 1999
Long noncoding RNAs in cancer and therapeutic potential
A Renganathan, E Felley-Bosco
Long Non Coding RNA Biology, 199-222, 2017
Role of nitric oxide in genotoxicity: implication for carcinogenesis
E Felley-Bosco
Cancer and Metastasis Reviews 17, 25-37, 1998
Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells
E Felley-Bosco, FC Bender, F Courjault-Gautier, C Bron, AFG Quest
Proceedings of the National Academy of Sciences 97 (26), 14334-14339, 2000
Functional inactivation of NF2/merlin in human mesothelioma
C Thurneysen, I Opitz, S Kurtz, W Weder, RA Stahel, E Felley-Bosco
Lung cancer 64 (2), 140-147, 2009
Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases
S Barceló‐Batllori, M André, C Servis, N Lévy, O Takikawa, P Michetti, ...
Proteomics 2 (5), 551-560, 2002
Functional studies of a germ-line polymorphism at codon 47 within the p53 gene.
E Felley-Bosco, A Weston, HM Cawley, WP Bennett, CC Harris
American journal of human genetics 53 (3), 752, 1993
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Y Shi, E Felley-Bosco, TM Marti, K Orlowski, M Pruschy, RA Stahel
BMC cancer 12 (1), 1-10, 2012
Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia
CP Felley, EM Felley, GD van Melle, P Frascarolo, E Jequier, F JP
American Journal of Physiology 256, E747-52, 1989
GAS5 long non-coding RNA in malignant pleural mesothelioma
A Renganathan, J Kresoja-Rakic, N Echeverry, G Ziltener, B Vrugt, I Opitz, ...
Molecular cancer 13 (1), 1-12, 2014
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
LL Belyanskaya, TM Marti, S Hopkins-Donaldson, S Kurtz, E Felley-Bosco, ...
Molecular cancer 6 (1), 1-13, 2007
Hippo/YAP pathway for targeted therapy
E Felley-Bosco, R Stahel
Translational lung cancer research 3 (2), 75, 2014
Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compound
AC Souici, J Mirkovitch, P Hausel, L K. Keefer, E Felley-Bosco
Carcinogenesis 21 (2), 281-287, 2000
Role of hedgehog signaling in malignant pleural mesothelioma
Y Shi, U Moura, I Opitz, A Soltermann, H Rehrauer, S Thies, W Weder, ...
Clinical Cancer Research 18 (17), 4646-4656, 2012
Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis
R Sidi, G Pasello, I Opitz, A Soltermann, M Tutic, H Rehrauer, W Weder, ...
European Journal of Cancer 47 (2), 326-332, 2011
Constitutive expression of inducible nitric oxide synthase in human bronchial epithelial cells induces c-fos and stimulates the cGMP pathway.
E Felley-Bosco, S Ambs, CJ Lowenstein, LK Keefer, CC Harris
American journal of respiratory cell and molecular biology 11 (2), 159-164, 1994
Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells
PA Knobel, IN Kotov, E Felley-Bosco, RA Stahel, TM Marti
Neoplasia 13 (10), 961-IN28, 2011
The system can't perform the operation now. Try again later.
Articles 1–20